These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Caligiuri G; Groyer E; Khallou-Laschet J; Al Haj Zen A; Sainz J; Urbain D; Gaston AT; Lemitre M; Nicoletti A; Lafont A Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1659-64. PubMed ID: 15933243 [TBL] [Abstract][Full Text] [Related]
3. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470 [TBL] [Abstract][Full Text] [Related]
4. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Caligiuri G; Rossignol P; Julia P; Groyer E; Mouradian D; Urbain D; Misra N; Ollivier V; Sapoval M; Boutouyrie P; Kaveri SV; Nicoletti A; Lafont A Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):618-23. PubMed ID: 16357310 [TBL] [Abstract][Full Text] [Related]
5. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374 [TBL] [Abstract][Full Text] [Related]
8. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells. Jiagang D; Li C; Wang H; Hao E; Du Z; Bao C; Lv J; Wang Y Biochem Biophys Res Commun; 2011 Aug; 411(3):523-9. PubMed ID: 21756879 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Afek A; Kogan E; Maysel-Auslender S; Mor A; Regev E; Rubinstein A; Keren G; George J Microvasc Res; 2009 May; 77(3):364-9. PubMed ID: 19323972 [TBL] [Abstract][Full Text] [Related]
10. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. Jacob S; Laury-Kleintop L; Lanza-Jacoby S J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326 [TBL] [Abstract][Full Text] [Related]
11. Natural regulatory T cells control the development of atherosclerosis in mice. Ait-Oufella H; Salomon BL; Potteaux S; Robertson AK; Gourdy P; Zoll J; Merval R; Esposito B; Cohen JL; Fisson S; Flavell RA; Hansson GK; Klatzmann D; Tedgui A; Mallat Z Nat Med; 2006 Feb; 12(2):178-80. PubMed ID: 16462800 [TBL] [Abstract][Full Text] [Related]
12. Effect of natural killer T cell activation on the initiation of atherosclerosis. van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872 [TBL] [Abstract][Full Text] [Related]
13. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083 [TBL] [Abstract][Full Text] [Related]